NCI | Technology Transfer

HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS

US Application 19/185,924
Filed on 2025-04-22

NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY

Read more about NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY

South Korea
10-2025-7009189
Filed on 2025-03-20

NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY

Read more about NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY

Japan
2025-039507
Filed on 2025-03-12

HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST BRAF WITH V600E MUTATION

Read more about HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST BRAF WITH V600E MUTATION

European Patent
23809936.0
Filed on 2025-05-27

HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST BRAF WITH V600E MUTATION

Read more about HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST BRAF WITH V600E MUTATION

US Application 19/118,121
Filed on 2025-04-03

T CELL RECEPTORS TARGETING MUTATED CDKN2A

Read more about T CELL RECEPTORS TARGETING MUTATED CDKN2A

European Patent
23814039.6
Filed on 2025-05-27

T CELL RECEPTORS TARGETING MUTATED CDKN2A

Read more about T CELL RECEPTORS TARGETING MUTATED CDKN2A

US Application 19/118,202
Filed on 2025-04-03

POTENT FGFR4-TARGETED ANTIBODY-DRUG CONJUGATES AND THEIR USE FOR TREATING CANCERS EXPRESSING FGFR4

Read more about POTENT FGFR4-TARGETED ANTIBODY-DRUG CONJUGATES AND THEIR USE FOR TREATING CANCERS EXPRESSING FGFR4

Patent Cooperation Treaty
PCT/US2025/023122
Filed on 2025-04-04

CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 AND/OR CD276 AND THEIR USE FOR TREATING SOLID TUMORS

Read more about CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 AND/OR CD276 AND THEIR USE FOR TREATING SOLID TUMORS

Patent Cooperation Treaty
PCT/US2025/028129
Filed on 2025-05-07

CHIMERIC ANTIGEN RECEPTORS TARGETING FGFR4 AND/OR CD276 AND USE THEREOF FOR THE TREATMENT OF CANCER

Read more about CHIMERIC ANTIGEN RECEPTORS TARGETING FGFR4 AND/OR CD276 AND USE THEREOF FOR THE TREATMENT OF CANCER

Patent Cooperation Treaty
PCT/US2025/024757
Filed on 2025-04-15

Subscribe to NCI